Hydroxychloroquine in systemic lupus erythematosus, anti-SSA/SSB, and antiphospholipid antibody-positive pregnancies

Pregnancies in patients with systemic lupus erythematosus (SLE) and those positive for anti-SSA/SSB or antiphospholipid antibodies carry a heightened risk of adverse pregnancy outcomes (APOs), including preeclampsia, preterm birth, and congenital heart block. Among available therapies, hydroxychloro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of obstetrics and gynecology
Hauptverfasser:	Saleh, Zeinab F., Somers, Emily C., Romero, Vivian C., Marder, Wendy
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Elsevier Inc 08.09.2025
Schlagworte:	adverse pregnancy outcomes antiphospholipid syndrome autoimmune rheumatic diseases congenital malformations hydroxychloroquine Obstetrics and Gynecology SSA/SSB positive systemic lupus erythematosus teratogenicity antiphospholipid syndrome systemic lupus erythematosus adverse pregnancy outcomes hydroxychloroquine autoimmune rheumatic diseases congenital malformations teratogenicity SSA/SSB positive
ISSN:	0002-9378, 1097-6868, 1097-6868
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!